MedAvail Holdings, Inc. (NASDAQ: MDVL) Stock Competitors & Peer Comparison
See MDVL's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MDVL and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MDVL | $1.80 | -43.22% | 2.9M | -0.05 | -$35.56 | N/A |
| RPRX | $56.57 | -2.09% | 25.1B | 10.78 | $5.25 | +1.60% |
| CORT | $117.80 | -2.80% | 12.7B | 336.57 | $0.35 | N/A |
| WBA | $11.98 | +0.50% | 10.4B | -1.64 | -$7.29 | +4.17% |
| KNSA | $78.53 | -0.90% | 6B | 80.96 | $0.97 | N/A |
| LQDA | $26.81 | -3.11% | 2.4B | 19.57 | $1.37 | N/A |
| PBH | $48.53 | -0.97% | 2.3B | 10.98 | $4.42 | N/A |
| HROWL | $25.61 | +0.19% | 1.4B | N/A | N/A | N/A |
| HROWM | $26.03 | -0.08% | 1.3B | N/A | N/A | N/A |
| LTGO | $15.71 | -1.94% | 945M | -6.23 | -$2.52 | N/A |
Stock Comparison
Royalty Pharma plc (NASDAQ: RPRX)
MDVL vs RPRX Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, RPRX has a market cap of 25.1B. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while RPRX trades at $56.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas RPRX's P/E ratio is 10.78. In terms of profitability, MDVL's ROE is -2.39%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, MDVL is more volatile compared to RPRX. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check RPRX's competition here
Corcept Therapeutics Incorporated (NASDAQ: CORT)
MDVL vs CORT Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, CORT has a market cap of 12.7B. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while CORT trades at $117.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas CORT's P/E ratio is 336.57. In terms of profitability, MDVL's ROE is -2.39%, compared to CORT's ROE of +0.08%. Regarding short-term risk, MDVL is more volatile compared to CORT. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check CORT's competition here
Walgreens Boots Alliance, Inc. (NASDAQ: WBA)
MDVL vs WBA Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while WBA trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas WBA's P/E ratio is -1.64. In terms of profitability, MDVL's ROE is -2.39%, compared to WBA's ROE of -0.57%. Regarding short-term risk, MDVL is more volatile compared to WBA. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check WBA's competition here
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA)
MDVL vs KNSA Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, KNSA has a market cap of 6B. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while KNSA trades at $78.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas KNSA's P/E ratio is 80.96. In terms of profitability, MDVL's ROE is -2.39%, compared to KNSA's ROE of +0.14%. Regarding short-term risk, MDVL is more volatile compared to KNSA. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check KNSA's competition here
Liquidia Corporation (NASDAQ: LQDA)
MDVL vs LQDA Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, LQDA has a market cap of 2.4B. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while LQDA trades at $26.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas LQDA's P/E ratio is 19.57. In terms of profitability, MDVL's ROE is -2.39%, compared to LQDA's ROE of +1.50%. Regarding short-term risk, MDVL is more volatile compared to LQDA. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check LQDA's competition here
Prestige Consumer Healthcare Inc. (NYSE: PBH)
MDVL vs PBH Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, PBH has a market cap of 2.3B. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while PBH trades at $48.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas PBH's P/E ratio is 10.98. In terms of profitability, MDVL's ROE is -2.39%, compared to PBH's ROE of +0.09%. Regarding short-term risk, MDVL is more volatile compared to PBH. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check PBH's competition here
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ: HROWL)
MDVL vs HROWL Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while HROWL trades at $25.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas HROWL's P/E ratio is N/A. In terms of profitability, MDVL's ROE is -2.39%, compared to HROWL's ROE of -1.04%. Regarding short-term risk, MDVL is more volatile compared to HROWL. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check HROWL's competition here
Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ: HROWM)
MDVL vs HROWM Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while HROWM trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas HROWM's P/E ratio is N/A. In terms of profitability, MDVL's ROE is -2.39%, compared to HROWM's ROE of -1.04%. Regarding short-term risk, MDVL is more volatile compared to HROWM. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check HROWM's competition here
Latigo Biotherapeutics Inc. (NASDAQ: LTGO)
MDVL vs LTGO Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, LTGO has a market cap of 945M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while LTGO trades at $15.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas LTGO's P/E ratio is -6.23. In terms of profitability, MDVL's ROE is -2.39%, compared to LTGO's ROE of N/A. Regarding short-term risk, MDVL is more volatile compared to LTGO. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check LTGO's competition here
Helus Pharma Inc. (NASDAQ: HELP)
MDVL vs HELP Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, HELP has a market cap of 650.8M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while HELP trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas HELP's P/E ratio is -2.52. In terms of profitability, MDVL's ROE is -2.39%, compared to HELP's ROE of -0.71%. Regarding short-term risk, MDVL is more volatile compared to HELP. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check HELP's competition here
Sinovac Biotech Ltd. (NASDAQ: SVA)
MDVL vs SVA Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, SVA has a market cap of 464.9M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while SVA trades at $6.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas SVA's P/E ratio is -5.68. In terms of profitability, MDVL's ROE is -2.39%, compared to SVA's ROE of -0.01%. Regarding short-term risk, MDVL is more volatile compared to SVA. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check SVA's competition here
Clinuvel Pharmaceuticals Ltd. (NASDAQ: CUVL)
MDVL vs CUVL Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, CUVL has a market cap of 275.6M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while CUVL trades at $5.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas CUVL's P/E ratio is 11.79. In terms of profitability, MDVL's ROE is -2.39%, compared to CUVL's ROE of N/A. Regarding short-term risk, MDVL is more volatile compared to CUVL. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check CUVL's competition here
Bristol-Myers Squibb Company Ce (NYSE: CELG-RI)
MDVL vs CELG-RI Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, CELG-RI has a market cap of 241M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while CELG-RI trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas CELG-RI's P/E ratio is N/A. In terms of profitability, MDVL's ROE is -2.39%, compared to CELG-RI's ROE of +0.47%. Regarding short-term risk, MDVL is more volatile compared to CELG-RI. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check CELG-RI's competition here
High Tide Inc. (NASDAQ: HITI)
MDVL vs HITI Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, HITI has a market cap of 226.7M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while HITI trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas HITI's P/E ratio is -9.53. In terms of profitability, MDVL's ROE is -2.39%, compared to HITI's ROE of -0.36%. Regarding short-term risk, MDVL is more volatile compared to HITI. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check HITI's competition here
Electra Therapeutics Inc. (NASDAQ: ETRA)
MDVL vs ETRA Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, ETRA has a market cap of 182.6M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while ETRA trades at $8.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas ETRA's P/E ratio is -3.25. In terms of profitability, MDVL's ROE is -2.39%, compared to ETRA's ROE of N/A. Regarding short-term risk, MDVL is more volatile compared to ETRA. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check ETRA's competition here
TRex Bio Inc. (NASDAQ: TRXB)
MDVL vs TRXB Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, TRXB has a market cap of 113.3M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while TRXB trades at $13.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas TRXB's P/E ratio is -5.51. In terms of profitability, MDVL's ROE is -2.39%, compared to TRXB's ROE of N/A. Regarding short-term risk, MDVL is more volatile compared to TRXB. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check TRXB's competition here
Citius Oncology, Inc. (NASDAQ: CTOR)
MDVL vs CTOR Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, CTOR has a market cap of 71.6M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while CTOR trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas CTOR's P/E ratio is -1.64. In terms of profitability, MDVL's ROE is -2.39%, compared to CTOR's ROE of -1.03%. Regarding short-term risk, MDVL is more volatile compared to CTOR. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check CTOR's competition here
Atlantic International Corp. (NASDAQ: ATLN)
MDVL vs ATLN Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, ATLN has a market cap of 68.6M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while ATLN trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas ATLN's P/E ratio is -0.68. In terms of profitability, MDVL's ROE is -2.39%, compared to ATLN's ROE of -83.20%. Regarding short-term risk, MDVL is more volatile compared to ATLN. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check ATLN's competition here
Retension Pharmaceuticals Inc. (NASDAQ: RTSN)
MDVL vs RTSN Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, RTSN has a market cap of 44.7M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while RTSN trades at $11.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas RTSN's P/E ratio is -4.57. In terms of profitability, MDVL's ROE is -2.39%, compared to RTSN's ROE of N/A. Regarding short-term risk, MDVL is more volatile compared to RTSN. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check RTSN's competition here
Rite Aid Corporation (NYSE: RAD)
MDVL vs RAD Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas RAD's P/E ratio is -0.05. In terms of profitability, MDVL's ROE is -2.39%, compared to RAD's ROE of +2.76%. Regarding short-term risk, MDVL is more volatile compared to RAD. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check RAD's competition here
Damora Therapeutics, Inc. (NASDAQ: GLTO)
MDVL vs GLTO Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while GLTO trades at $21.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas GLTO's P/E ratio is -1.78. In terms of profitability, MDVL's ROE is -2.39%, compared to GLTO's ROE of -0.83%. Regarding short-term risk, MDVL is more volatile compared to GLTO. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check GLTO's competition here
Nasus Pharma Ltd. (AMEX: NSRX)
MDVL vs NSRX Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, NSRX has a market cap of 27.8M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while NSRX trades at $3.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas NSRX's P/E ratio is -4.49. In terms of profitability, MDVL's ROE is -2.39%, compared to NSRX's ROE of -1.59%. Regarding short-term risk, MDVL is more volatile compared to NSRX. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check NSRX's competition here
SCYNEXIS, Inc. (NASDAQ: SCYX)
MDVL vs SCYX Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, SCYX has a market cap of 25.1M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while SCYX trades at $3.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas SCYX's P/E ratio is -1.17. In terms of profitability, MDVL's ROE is -2.39%, compared to SCYX's ROE of -0.21%. Regarding short-term risk, MDVL is more volatile compared to SCYX. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check SCYX's competition here
Cosmos Health Inc. (NASDAQ: COSM)
MDVL vs COSM Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, COSM has a market cap of 20.8M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while COSM trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas COSM's P/E ratio is -0.52. In terms of profitability, MDVL's ROE is -2.39%, compared to COSM's ROE of -1.19%. Regarding short-term risk, MDVL is more volatile compared to COSM. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check COSM's competition here
Cerenome, Inc. (NASDAQ: CNSY)
MDVL vs CNSY Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, CNSY has a market cap of 12M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while CNSY trades at $1.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas CNSY's P/E ratio is -0.41. In terms of profitability, MDVL's ROE is -2.39%, compared to CNSY's ROE of -3.94%. Regarding short-term risk, MDVL is more volatile compared to CNSY. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check CNSY's competition here
Biofrontera Inc. (NASDAQ: BFRI)
MDVL vs BFRI Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, BFRI has a market cap of 11.4M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while BFRI trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas BFRI's P/E ratio is -1.62. In terms of profitability, MDVL's ROE is -2.39%, compared to BFRI's ROE of -1.28%. Regarding short-term risk, MDVL is more volatile compared to BFRI. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check BFRI's competition here
China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD)
MDVL vs CJJD Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas CJJD's P/E ratio is -0.46. In terms of profitability, MDVL's ROE is -2.39%, compared to CJJD's ROE of -0.25%. Regarding short-term risk, MDVL is more volatile compared to CJJD. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check CJJD's competition here
SunLink Health Systems, Inc. (AMEX: SSY)
MDVL vs SSY Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while SSY trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas SSY's P/E ratio is -2.86. In terms of profitability, MDVL's ROE is -2.39%, compared to SSY's ROE of -0.09%. Regarding short-term risk, MDVL is more volatile compared to SSY. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check SSY's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
MDVL vs SCNX Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, SCNX has a market cap of 5.3M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while SCNX trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas SCNX's P/E ratio is -1.54. In terms of profitability, MDVL's ROE is -2.39%, compared to SCNX's ROE of -0.54%. Regarding short-term risk, MDVL is more volatile compared to SCNX. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check SCNX's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMS)
MDVL vs BGMS Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, BGMS has a market cap of 5.1M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while BGMS trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas BGMS's P/E ratio is -0.26. In terms of profitability, MDVL's ROE is -2.39%, compared to BGMS's ROE of -0.32%. Regarding short-term risk, MDVL is more volatile compared to BGMS. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check BGMS's competition here
POMDOCTOR Ltd (NASDAQ: POM)
MDVL vs POM Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, POM has a market cap of 4.7M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while POM trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas POM's P/E ratio is -0.12. In terms of profitability, MDVL's ROE is -2.39%, compared to POM's ROE of +0.16%. Regarding short-term risk, MDVL is more volatile compared to POM. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check POM's competition here
Eocene Ltd. (NASDAQ: EOCN)
MDVL vs EOCN Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, EOCN has a market cap of 3.3M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while EOCN trades at $3.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas EOCN's P/E ratio is -0.23. In terms of profitability, MDVL's ROE is -2.39%, compared to EOCN's ROE of N/A. Regarding short-term risk, MDVL is more volatile compared to EOCN. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check EOCN's competition here
Biofrontera Inc. (NASDAQ: BFRIW)
MDVL vs BFRIW Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, BFRIW has a market cap of 3.2M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while BFRIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas BFRIW's P/E ratio is -0.01. In terms of profitability, MDVL's ROE is -2.39%, compared to BFRIW's ROE of -1.28%. Regarding short-term risk, MDVL is more volatile compared to BFRIW. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check BFRIW's competition here
Paranovus Entertainment Technology Ltd. (NASDAQ: PAVS)
MDVL vs PAVS Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, PAVS has a market cap of 2.9M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while PAVS trades at $3.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas PAVS's P/E ratio is -0.04. In terms of profitability, MDVL's ROE is -2.39%, compared to PAVS's ROE of -0.46%. Regarding short-term risk, MDVL is more volatile compared to PAVS. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check PAVS's competition here
ETHZilla Corporation Warrant (NASDAQ: ATNFW)
MDVL vs ATNFW Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while ATNFW trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas ATNFW's P/E ratio is N/A. In terms of profitability, MDVL's ROE is -2.39%, compared to ATNFW's ROE of -2.15%. Regarding short-term risk, MDVL is more volatile compared to ATNFW. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check ATNFW's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMSP)
MDVL vs BGMSP Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while BGMSP trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas BGMSP's P/E ratio is -0.84. In terms of profitability, MDVL's ROE is -2.39%, compared to BGMSP's ROE of -0.32%. Regarding short-term risk, MDVL is more volatile compared to BGMSP. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check BGMSP's competition here
AstraZeneca PLC ADRhedged (AMEX: AZNH)
MDVL vs AZNH Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while AZNH trades at $53.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas AZNH's P/E ratio is 38.35. In terms of profitability, MDVL's ROE is -2.39%, compared to AZNH's ROE of +0.00%. Regarding short-term risk, MDVL is more volatile compared to AZNH. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check AZNH's competition here
Leafly Holdings, Inc. (NASDAQ: LFLYW)
MDVL vs LFLYW Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while LFLYW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, MDVL's ROE is -2.39%, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, MDVL is more volatile compared to LFLYW. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check LFLYW's competition here
ProPhase Labs, Inc. (NASDAQ: PRPH)
MDVL vs PRPH Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, PRPH has a market cap of 119.1K. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while PRPH trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas PRPH's P/E ratio is N/A. In terms of profitability, MDVL's ROE is -2.39%, compared to PRPH's ROE of -13.59%. Regarding short-term risk, MDVL is more volatile compared to PRPH. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check PRPH's competition here
Express Scripts Holding Company (NASDAQ: ESRX)
MDVL vs ESRX Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, ESRX has a market cap of 0. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while ESRX trades at $92.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas ESRX's P/E ratio is 10.69. In terms of profitability, MDVL's ROE is -2.39%, compared to ESRX's ROE of +0.26%. Regarding short-term risk, MDVL is more volatile compared to ESRX. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check ESRX's competition here
Shire plc (NASDAQ: SHPG)
MDVL vs SHPG Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, SHPG has a market cap of 0. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while SHPG trades at $179.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas SHPG's P/E ratio is 11.35. In terms of profitability, MDVL's ROE is -2.39%, compared to SHPG's ROE of +0.13%. Regarding short-term risk, MDVL is more volatile compared to SHPG. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check SHPG's competition here
Impax Laboratories, Inc. (NASDAQ: IPXL)
MDVL vs IPXL Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, IPXL has a market cap of 0. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while IPXL trades at $18.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas IPXL's P/E ratio is -10.11. In terms of profitability, MDVL's ROE is -2.39%, compared to IPXL's ROE of -1.16%. Regarding short-term risk, MDVL is more volatile compared to IPXL. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check IPXL's competition here
POZEN Inc. (NASDAQ: POZN)
MDVL vs POZN Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, POZN has a market cap of 0. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while POZN trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas POZN's P/E ratio is N/A. In terms of profitability, MDVL's ROE is -2.39%, compared to POZN's ROE of +0.61%. Regarding short-term risk, MDVL is more volatile compared to POZN. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check POZN's competition here
Caraco Pharmaceutical Laboratories Ltd (AMEX: CPD)
MDVL vs CPD Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, CPD has a market cap of 0. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while CPD trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas CPD's P/E ratio is N/A. In terms of profitability, MDVL's ROE is -2.39%, compared to CPD's ROE of N/A. Regarding short-term risk, MDVL is more volatile compared to CPD. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check CPD's competition here
Orexigen Therapeutics, Inc. (NASDAQ: OREX)
MDVL vs OREX Comparison October 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, OREX has a market cap of 0. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while OREX trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas OREX's P/E ratio is -0.14. In terms of profitability, MDVL's ROE is -2.39%, compared to OREX's ROE of -0.54%. Regarding short-term risk, MDVL is more volatile compared to OREX. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check OREX's competition here